dehydroepiandrosterone sulfate has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abroun, S; Asaoku, H; Ishikawa, H; Kawano, MM; Li, FJ; Liu, S; Ma, Z; Obata, M; Otsuyama, K; Tsuyama, N; Zheng, X | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Multiple Myeloma
Article | Year |
---|---|
Dehydroepiandrosterone can inhibit the proliferation of myeloma cells and the interleukin-6 production of bone marrow mononuclear cells from patients with myeloma.
Topics: Animals; Bone Marrow Cells; Cell Growth Processes; Cell Line, Tumor; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Interleukin-6; Leukocytes, Mononuclear; Lymphoma; Male; Mice; Mice, SCID; Mice, Transgenic; Multiple Myeloma; NF-kappa B; PPAR-beta; Proteins; Sex Factors; Waldenstrom Macroglobulinemia; X-Linked Inhibitor of Apoptosis Protein | 2005 |